Callan Family Office’s AB InBev BUD Stock Holding History
Bought
Maintained
Sold
Other funds holding BUD
DC
Callan Family Office's BUD Position: Q1 2026 in Review
Callan Family Office reduced its AB InBev (BUD) stake by 2% in Q1 2026, selling an estimated $157K and leaving 105,167 shares worth $7.3M. The position accounts for 0.17% of the portfolio, ranked #125.
Callan Family Office first reported a position in BUD in Q1 2023 and has held it in 7 quarters since. 544 funds tracked by Wall St. Rank hold BUD as of Q1 2026.
- Callan Family Office held 105,167 shares of AB InBev worth $7.3M as of Q1 2026.
- Callan Family Office sold 2,170 AB InBev shares in Q1 2026, an estimated $157K.
- AB InBev made up 0.17% of Callan Family Office's portfolio in Q1 2026, its #125 holding.
- Callan Family Office first reported a position in AB InBev in Q1 2023 and has held it in 7 quarters since.
- 544 funds tracked by Wall St. Rank held AB InBev as of Q1 2026.
Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.